
| Serial Number | 79428966 |
| Word Mark | KEDRION BIOPHARMA |
| Filing Date | Monday, February 10, 2025 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, April 14, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, April 14, 2026 |
| NOT AVAILABLE | "BIOPHARMA" |
| Goods and Services | Scientific and technological services, namely, research, analysis, and testing, in the field of pharmaceuticals, medical disorders and the treatment of medical disorders, and clinical trials, ; medical and pharmacological research services; providing information and data in relation to medical research and development in the field of pharmaceuticals and clinical trials; providing scientific research information in the field of medical disorders and their treatment; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; medical research; biological research, clinical research and medical research in the field of pharmaceuticals and clinical trials; design and development of computer software for use with medical technology; scientific research on the subject of pharmaceuticals; providing information technology services for the pharmaceutical and healthcare industries; providing information about the results of clinical trials for pharmaceutical products |
| Goods and Services | Medical services and small molecule therapy services; medical consultancy in relation to medical and pharmaceutical field; health center services for therapeutical purposes |
| Description of Mark | The mark consists of the wording "KEDRION" having the letter "K" formed partially by a liquid shaped stylization above the wording "BIOPHARMA". |
| Goods and Services | Pharmaceutical products for the treatment of primary and secondary immunodeficiency disorders, coagulation disorders, autoimmune diseases treatable with immunoglobulins, and other conditions treatable with plasma derived therapies, biologic therapies, and small molecules therapies; Pharmaceutical preparations for the treatment of primary and secondary immunodeficiency disorders, coagulation disorders, autoimmune diseases treatable with immunoglobulins, and other conditions treatable with plasma derived therapies, biologic therapies, and small molecules therapies |
| Goods and Services | Business management; business administration; office functions in the nature of regulatory documentation management for biopharmaceutical activities and pharmaceutical regulatory compliance for others; Business administration in the nature of sales administration |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, July 31, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, July 31, 2025 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, July 31, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, July 31, 2025 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | KEDRION S.p.A. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | IT |
| Party Name | KEDRION S.p.A. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | IT |
| Event Date | Event Description |
| Thursday, July 31, 2025 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, August 1, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, August 1, 2025 | APPLICATION FILING RECEIPT MAILED |
| Saturday, August 2, 2025 | ASSIGNED TO EXAMINER |
| Monday, August 11, 2025 | NON-FINAL ACTION WRITTEN |
| Tuesday, August 12, 2025 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Wednesday, September 24, 2025 | REFUSAL PROCESSED BY MPU |
| Wednesday, September 24, 2025 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Friday, October 10, 2025 | REFUSAL PROCESSED BY IB |
| Wednesday, March 18, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, March 18, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, March 18, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, March 18, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, April 8, 2026 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, April 14, 2026 | PUBLISHED FOR OPPOSITION |
| Tuesday, April 14, 2026 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |